Bleichroeder LP’s RenovoRx RNXT Stock Holding History

Bleichroeder LP’s Portfolio RNXT Stock Details RNXT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.63M	Hold	1,666,098	–	–	0.29%	38
2026 Q1	$1.68M	Buy	1,666,098 +1,066,098	+178%	+$1.03M	0.29%	32
2025 Q4	$504K	Buy	600,000 +61,379	+11%	+$61.5K	0.09%	42
2025 Q3	$684K	Buy	538,621 +38,621	+8%	+$45.9K	0.13%	40
2025 Q2	$658K	Hold	500,000	–	–	0.16%	39
2025 Q1	$495K	Buy	+500,000	New	+$582K	0.13%	41

Other funds holding RNXT

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WANY

Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Bleichroeder LP's RNXT Position: Q2 2026 in Review

Bleichroeder LP held its RenovoRx (RNXT) position steady in Q2 2026 at 1,666,098 shares worth $1.63M. The position accounts for 0.29% of the portfolio, ranked #38.

Bleichroeder LP first reported a position in RNXT in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.68M in Q1 2026. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

Bleichroeder LP held 1,666,098 shares of RenovoRx worth $1.63M as of Q2 2026.
Bleichroeder LP left its RenovoRx share count unchanged in Q2 2026.
RenovoRx made up 0.29% of Bleichroeder LP's portfolio in Q2 2026, its #38 holding.
Bleichroeder LP first reported a position in RenovoRx in Q1 2025 and has held it in 6 quarters since.
Bleichroeder LP's RenovoRx position peaked at $1.68M in Q1 2026.
28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on Bleichroeder LP's 13F filing for Q2 2026, filed 13 Aug 2026.